OSPERZO 3 g, granules with extended release 30 sachets of 5.48 g
Active ingredients: Mesalazine
Commercialized according to BDPMDispensing in France: Prescription only
Granules with extended release30 sachets of 5.48 gorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OSPERZO 3 g, granulés à libération prolongée
- Pharmaceutical form
- granulés à libération prolongée
- Route of administration
- orale
- Presentation description
- 30 sachet(s) polyester aluminium polyéthylène de 5,48 g de granulés
- Marketing authorisation holder
- FALK PHARMA
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Mar 2024
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60329160CIP73026475CIP133400930264751Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉSALAZINEgranulés | 3 g · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.